Practically all biological tests have a limited sensitivity and specificity, that is, a limited capability to elicit positive response in a truly diseased individual and a limited capability of not giving positive response in a truly non-diseased individual. These concepts are fundamental for a proper application of any biological test. Treatment of false positives may for some diseases and treatments be a heavy burden; for other conditions it may be close to harmless. Non-treatment of false negatives for serious diseases may cause considerable concern. The balance between the seriousness of the disease and the seriousness of the unavoidable side effects is crucial.
Several biological tests for which these properties have been examined are characterised by a relatively unambiguous definition of the disease. Pulmonary tuberculosis is thus clearly defined by bacilli in the sputum. Tuberculin tests, x ray examinations, and bacteriological examinations of sputum specimens are tests for which the sensitivity and specificity have been thoroughly examined.
Whether hypertension is a disease or only a risk factor is debatable, but the fact is that essential hypertension is treated as if it were a disease. This makes a study of the specificity and sensitivity of the measurements essential. Such a study is complicated by the fact that hypertension is not an either-or phenomenon. The The concept of 'true positives' somehow presupposes that there are two groups of hypertensives, those who (predestined) will be hit by complications and those who will not. However, the truth may also be that they all share an increased risk. For the calculations, this distinction is, however, immaterial.
In this paper I have used the excess mortality to define the true positives. The frequency of blood pressure-related complications in the present material is not known, but it has tentatively been simulated to be twice the mortality in order to check the validity of the conclusions.
Materials and methods
The statistical material is a 10-year follow-up of mortality of 70 000 people (general population) in the city of Bergen, Norway. The number of deaths is about 10 000. The blood pressure of the 70 000 people was measured and recorded by standardised methods in 19631 under conditions of mass screening. The pressure was measured twice, with an interval of about five minutes, and the last measurement is used in this paper.
The follow-up of mortality was carried out by matching the blood pressure files with the death files in the Central Bureau of Statistics by means of the individual identification number system. The material is neither completely untreated, nor was it subjected to a systematic follow-up, and it is 53 54 supposed to be only moderately affected by treatment, except at the highest pressure levels. Table 1 gives the total population according to diastolic blood pressure at the initial measurement and the 10-year mortality.
For both sexes and all age groups the mortality increased by blood pressure, and this increase starts at a very low level. For extremely low values of blood pressure an increased mortality is also observed. In this paper I have used the minimum level of mortality as a basis and have calculated the excess number of deaths occurring at the various higher levels of blood pressure. The sum of these excess deaths is the estimate of the true positives.
To obtain estimates of sensitivity and specificity, the boxes in the following table must be determined. Calculations presented in this paper are limited, for the sake of simplicity, to the diastolic pressure (5th phase). Similar calculations can, of course, be carried out for the systolic pressure or for any function of the two pressures. These results will be presented elsewhere in a paper on the relative properties of the diastolic and systolic pressure.
Results

SENSITIVITY AND SPECIFICITY
The procedure is demonstrated in Table 2 for males aged 50-59. The lowest level of mortality is observed for the diastolic blood pressure levels of 50-59 (0. 1375) and of 60-69 mm Hg (0. 1398). The excess mortality for higher pressure values is estimated as the excess above 0 1398 (column 6). Out of a total number of 888 deaths, 184 were in excess of the expected mortality and could thus be reasonably attributed to 'elevated blood pressure'. The figure 184 is thus an estimate of the true positive cases. Is this a reasonable figure? It is known that cardiovascular diseases are positively correlated with blood pressure. In a general cohort of 50-59-year-old Norwegian males, the 10-year frequency of deaths due to ICD code number 410 (heart infarction)2 is estimated at 4-5%, and due to ICD 430-438 1-49  22  3  13  2  25  15  23  13  50  106  5  80  1 1  106  39  90  59  60  735  28  565  79  501  201  310  182  70  1740  105  1458  226  1197  406  572  348  80  1656  104  1669  275  1201  450  595  366  90  693  70  830  171  729  300  357  237  100  191  18  288  67  296  165  169  122  110  47  10  91  37  113  72  70  56  120  10  4  29  16  44  32  29  23  2130   10  4  11  4  20  14  13  10   5210  351   5034   888  4232  1694  2228  1416   FEMALES   1-49  32  3  25  2  38  10  46  29   50  180  3  73  8  97  25  79  43  60  1119  29  698  38  557  105   370  166  70  2460  75  1941  120  1498  239  753  322   80  2007  57  2431  161  1957  392  900  424  90  882  32  1421  137  1325  346  715  375  100  216  14  504  62  629  194  395  230  110  66  7   166  31  288  97  165   i11   120  18  4   63  19  81  34  48  32  a130  9  3  29  7  39  21  20  17   6989  227  7351  585  6509  1463  3491  1749 group.bmj.com on June 22, 2017 -Published by http://jech.bmj.com/ Downloaded from (cerebrovascular accident) it is 1%, which together are 5-5%. In the Bergen material (Table 1) Up to the level of 70 mm Hg all persons will be true negatives (column 9). For higher values, the true negatives are calculated by subtracting the true positives from the total (column 8 minus column 7). The specificity is then calculated at various pressure levels from column 9. For low levels, for instance below 60 mm Hg, the specificity is very low: 1-9%. Thus, if 60 mm Hg and above were defined as hypertension, (100 -1*9)% = 98-1% of the treated would be true negatives and therefore over-treated.
Similar calculations for other age groups and for females are summarised in Table 3 and for males aged 50-59 in Fig. 1 Table 2 Calculations of sensitivity and specificity of blood pressure measurement for males aged 50-59 The results can also instructively be presented by a so-called ROC-curve3 as in Fig. 2 
False negative (ACJ) means a non-detected true case of hypertension. Non-treatment will presumably increase the probability of reduced survival. Calculations of life years lost have been carried out in our material5 and an extract is given in Table 4 . It should be noted, however, that non-detection is not final. A later chance of being detected will occur, depending among other things upon the intensity of the case-finding programme.
False positive (ACp) means a wasted, useless long-term treatment, including the probability of side effects. Often the treatment will be lifelong, with little chance of getting out of the treatment situation.
The simultaneous assessment of ACp and ACn is a question of clinical judgment, but the immediate impression is that ACsIACn will be considerably larger than 1: that is, that all costs, as defined above, connected with a false positive is larger than the costs connected with a false negative.
The consequence is that the optimal position on the ROC-curve will be far to the left in the diagram.
CLINICAL PRACTICE
Physicians in general practice cannot be expected to take their decisions explicitly according to rules as indicated in this paper. The important question is whether they deviate from the optimal position to any significant extent. Studies of clinical methods in Norway67 indicate a great variation in general practice. However, four particularly experienced clinicians, presented with estimates of the potential benefits and the hazards of blood pressure treatment, had no difficulties in reaching an agreement on the threshold above which treatment must be offered.-The value varied by the age of the patient and for patients aged 50-59 it was -107 mm Hg diastolic pressure on the average. It can be seen from Fig. 2 that this compares with a point on the ROC-curve far to the left and close to the optimal area.
ALTERNATIVE DEFINITION OF 'TRUE POSITIVES'
The calculations presented here are limited to estimates of excess mortality. Most complications are, however, non-fatal. Morbidity events should therefore be included. However, we do not have access to similar figures on morbidity in our material. If we assume the total incidence to be, say, twice the mortality, we can simulate the effect of this on the sensitivity and specificity. Table 5 gives the result of this simulation and demonstrates that neither the sensitivity nor the specificity is changed on this basis. Our estimates of the two properties remain unchanged at this low level of incidence. The higher prevalence will change the optimal position on the ROC-curve. If 'disease' = 3 * mortality, simulating an added morbidity, P (D+) will be:
184 -3/5034 = 0 1097 and the ratio P (D-)/P (D+) = 8*1, which also indicates a rather steep slope (see Fig. 2 ). 
